Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Comprehensive Healthcare Systems EV-to-EBITDA?
Comprehensive Healthcare SystemsCMHSF 26 EV-to-EBITDA is -4.38 as of Jul. 30, 2026. GuruFocus rates CMHSF with a GF Score™ of 26/100 and a GF Value™ of $0.07 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 509 Healthcare Providers & Services companies, Comprehensive Healthcare Systems ranks worse than 196463.46% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Comprehensive Healthcare Systems's enterprise value is $9.09 Mil.
Comprehensive Healthcare Systems's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-2.08 Mil. Therefore, Comprehensive Healthcare Systems's EV-to-EBITDA for today is -4.38.
The historical rank and industry rank for Comprehensive Healthcare Systems's EV-to-EBITDA or its related term are showing as below:
CMHSF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -15.92 Med: -1.4 Max: 67.87
Current: -4.49
During the past 7 years, the highest EV-to-EBITDA of Comprehensive Healthcare Systems was 67.87. The lowest was -15.92. And the median was -1.40.
CMHSF's EV-to-EBITDA is ranked worse than 100% of 509
companies
in the Healthcare Providers & Services industry
Industry Median: 11.01
vs CMHSF: -4.49
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Comprehensive Healthcare Systems (OTCPK:CMHSF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Comprehensive Healthcare Systems's PE Ratio (TTM) for today is calculated as:
Comprehensive Healthcare Systems's share price for today is $0.29415.
Comprehensive Healthcare Systems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.155.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Comprehensive Healthcare Systems EV-to-EBITDA Chart
For the Health Information Services subindustry, Comprehensive Healthcare Systems's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Comprehensive Healthcare Systems EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Comprehensive Healthcare Systems's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Comprehensive Healthcare Systems's EV-to-EBITDA falls into.
Comprehensive Healthcare Systems's current Enterprise Value is $9.09 Mil.
Comprehensive Healthcare Systems's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.08 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Comprehensive Healthcare Systems (CMHSF) has a EV-to-EBITDA of -4.38 as of Jul. 30, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Comprehensive Healthcare Systems. According to the industry distribution chart, Comprehensive Healthcare Systems ranks #999999 out of 509 companies in the Healthcare Providers & Services industry.
Is Comprehensive Healthcare Systems' EV-to-EBITDA too high?
Comprehensive Healthcare Systems' current EV-to-EBITDA is -4.38. Based on the distribution chart, Comprehensive Healthcare Systems ranks #999999 out of 509 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Comprehensive Healthcare Systems has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Comprehensive Healthcare Systems' EV-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Comprehensive Healthcare Systems ranks #999999 out of 509 companies for EV-to-EBITDA. This places Comprehensive Healthcare Systems in the lower half of its industry. The industry median EV-to-EBITDA is 11.01. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.01, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Comprehensive Healthcare Systems. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Comprehensive Healthcare Systems's current EV-to-EBITDA is -4.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Comprehensive Healthcare Systems stock overvalued right now?
Based on GuruFocus' analysis, Comprehensive Healthcare Systems (CMHSF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.07, compared to a current price of $0.29 — trading 320.2% above its estimated fair value. The current EV-to-EBITDA is -4.38. Comprehensive Healthcare Systems' overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Comprehensive Healthcare Systems (CMHSF), the current EV-to-EBITDA is -4.38 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Comprehensive Healthcare Systems (CMHSF) Overvalued in 2026?
Based on GuruFocus' analysis, Comprehensive Healthcare Systems stock appears to be overvalued.
The current stock price of $0.29 is trading 320.2% above its estimated GF Value™ of $0.07.
GuruFocus considers Comprehensive Healthcare Systems to be Significantly Overvalued.
Key valuation signals for CMHSF:
EV-to-EBITDA: -4.38
GF Value™: $0.07 vs. price of $0.29 (320.2% above fair value)
No single metric tells the full story. See the CMHSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Comprehensive Healthcare Systems Business Description
Comprehensive Healthcare Systems Inc is a vertically integrated software as a services (SaaS) company focused on digitizing healthcare with Healthcare Benefits Administration solutions, providing reliable and high-volume transaction-capable systems. The company's Novus 360 Healthcare Welfare and Benefits Administration (HWBA) SaaS platform is used by clients for all aspects of healthcare benefits administration (including self-funded employers, providers, and labor unions), providing healthcare administrative software and technology-enabled services. It provides healthcare administrative software, licensing and maintenance services to various interests in the healthcare industry, including insurance companies, hospitals, doctors and labor unions. It operates in single segment.
26GF Score
Get the complete analysis for CMHSF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CMHSF has been successfully added to your 
